Canada’s Law on Compulsory Licensing for Export – Update: 3 December 2009

On the evening of December 2, 2009, in a victory for treatment activists, Canada’s House of Commons voted narrowly (143 in favour, 127 against) to move forward with a private member’s bill that would streamline “Canada’s Access to Medicines Regime” (CAMR), the law originally passed in 2004 to implement the WTO General Council Decision of August 30, 2003 on compulsory licensing of patented pharmaceutical products for export.